Is the metabolic dysfunction-associated steatotic liver disease a predictor of chronic kidney disease?

Table 6 Degree of fibrosis and steatosis based on the stage of chronic kidney disease, mean ± SD/n (%)

Variables	CKD stage-I (n = 9)	CKD stage-II (n = 6)	CKD stage-III (n = 5)	P value
FIB-4	2.55 ± 0.65	3.01 ± 0.68	3.60 ± 0.78	< 0.001
APRI	1.22 ± 0.39	1.51 ± 0.80	1.85 ± 0.40	< 0.001
FibroScan score	8.01 ± 3.90	11.33 ± 4.19	16.76 ± 3.33	< 0.001
Degree of fibrosis				0.001
F0	2 (22.2)	1 (16.7)	0
F1	4 (44.4)	2 (33.3)	0
F2	3 (33.4)	1 (16.7)	1 (20)
F3	0	1 (16.7)	2 (40)
F4	0	1 (16.7)	2 (40)
Steatosis score	218.09 ± 44.40	235.90 ± 78.70	292.21 ± 66.89	< 0.001
Degree of steatosis				0.013
S0	3 (33.4)	1 (16.7)	0
S1	2 (22.2)	2 (33.3)	0
S2	2 (22.2)	2 (33.3)	2 (40)
S3	2 (22.2)	1 (16.7)	3 (60)

APRI: Aspartate aminotransferase to platelet ratio index; CKD: Chronic kidney disease; FIB-4: Fibrosis-4 index; F: Fibrosis; S: Steatosis.